Public Policy Page Contents
- PSAB Documents (Statements, Reports, Testimony and Monthly Newsletters)
- Research and Development Funding for FY 2015
- Contact Congress (Legislative Action Center)
- Clinical Microbiology Resources
- Public and Scientific Affairs Board Information
- Federal and State Government Links
- Congressional Science Fellowship
Check Here for Critical Public Policy Information
- Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
- Committee on the Status of Women in Microbiology
- Committee on Microbiological Issues Impacting Minorities
Public and Scientific Affairs Board (PSAB)
Underlying the ASM's dedication to the advancement of scientific knowledge is its commitment that science serve the public interest. To address scientific matters affecting the public interest, the ASM created the Public and Scientific Affairs Board (PSAB) in 1979. The PSAB monitors legislation and regulation and develops positions for the Society on public policy issues. The PSAB encourages the adoption of sound policies affecting science and technology and the discipline of microbiology. The PSAB responds to policy makers who may request or require an understanding of research and technology in microbiology. It also communicates microbiological issues to the public.
What's New in Public Policy?
The October issue of the e-Public Policy Update has been published by the Office of Public Affairs.
October 29, 2014 - ASM Statement on CDC Interim Guidance on Monitoring and Movement of Persons with Suspected Ebola Contact
The ASM issued a statement regarding the Centers for Disease Control and Prevention new Interim Guidance on Monitoring and Movement of Persons with Suspected Ebola Contact.
October 28, 2014 - White House Office of Science and Technology Policy Challenge to Develop Ebola Tools
The ASM sent a message to members about a White House Office of Science and Technology Policy program that solicits the global community to share innovative ideas that deliver practical and cost-effective innovations to address this crisis, to improve delivery of care, and stem the spread of Ebola virus disease.
The White House Office of Science and Technology Policy announced that the U.S. government will undertake a deliberative process to assess the risks and benefits of certain gain-of-function (GOF) experiments with influenza, SARS, and MERS viruses in order to develop a new Federal policy regarding the funding of this research.
The October issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities.
The September issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs
The ASM submitted comments on the strategic plan of the National Institute of General Medical Sciences.
September 25, 2014 - United States Government Policy for Institutional Oversight of Life Sciences DURC
On September 24 the United States Government issued the final US Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC. The Office of Public Affairs sent a notice to members about the Oversight document.
September 23, 2014 - ASM Letter to the US HHS Concerning Scientific Resources in Response to the Ebola Virus Outbreak
The ASM sent a letter to Sylvia M. Burwell, Secretary US Department of Health & Human Services with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak.
September 23, 2014 - ASM Letter to the UN Concerning Scientific Resources in Response to the Ebola Virus Outbreak
The ASM sent a letter to David Nabarro, M.D., Senior United Nations System Coordinator for Ebola Virus Disease with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak.